Find out how stereotactic body radiation therapy (SBRT) with CyberKnife® can benefit prostate cancer patients. Below are some advantages from our medical director Dr. Jonathan Tay.
What sets CyberKnife apart from other treatment options?
CyberKnife offers patients a noninvasive treatment option that doesn’t impede on their lifestyle. CyberKnife can treat prostate cancer patients in five or fewer sessions, a much shorter time period than conventional forms of treatment, and patients can return to their normal routines immediately following each session. The accuracy of treatment can also reduce side effects associated with other forms of treatment for prostate cancer. View our treatment options overview here.
How is SBRT with CyberKnife different from conventional radiation therapy?
CyberKnife has the ability to directly target the prostate while compensating for normal patient movements, which minimizes radiation exposure to surrounding healthy tissue. Treatment time is also significantly shorter given traditional radiation therapy can last up to seven to eight weeks. CyberKnife treatment for prostate cancer is completed within five sessions over a period lasting one to two weeks.
Is SBRT more expensive than other treatment options?
No, a recent study titled “Cost-Effectiveness Analysis of SBRT Versus IMRT” compared the cost of SBRT and IMRT for treatment of low- to intermediate-risk prostate cancer. The study revealed that on average the cost of SBRT was nearly $14,000 less than IMRT. Learn more about the study here.
To find out whether you may be a candidate for CyberKnife treatment, request more information.